Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia

BackgroundCachexia is a paraneoplastic syndrome that accompanies and compromises cancer treatment, especially in advanced stages, affecting the metabolism and function of several organs. The adipose tissue is the first to respond to the presence of the tumor, contributing to the secretion of factors...

Full description

Bibliographic Details
Main Authors: Joyce de Cassia Rosa de Jesus, Ariene Soares de Pinho Murari, Katrin Radloff, Ruan Carlos Macêdo de Moraes, Raquel Galvão Figuerêdo, Ana Flavia Marçal Pessoa, José César Rosa-Neto, Emídio Marques Matos-Neto, Paulo S. M. Alcântara, Flavio Tokeshi, Linda Ferreira Maximiano, Fang Chia Bin, Fernanda Bellotti Formiga, José P. Otoch, Marilia Seelaender
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.729182/full
id doaj-27a84ec0b70242688c13eb621805645e
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Joyce de Cassia Rosa de Jesus
Ariene Soares de Pinho Murari
Katrin Radloff
Ruan Carlos Macêdo de Moraes
Raquel Galvão Figuerêdo
Ana Flavia Marçal Pessoa
José César Rosa-Neto
Emídio Marques Matos-Neto
Paulo S. M. Alcântara
Flavio Tokeshi
Linda Ferreira Maximiano
Fang Chia Bin
Fernanda Bellotti Formiga
José P. Otoch
José P. Otoch
Marilia Seelaender
spellingShingle Joyce de Cassia Rosa de Jesus
Ariene Soares de Pinho Murari
Katrin Radloff
Ruan Carlos Macêdo de Moraes
Raquel Galvão Figuerêdo
Ana Flavia Marçal Pessoa
José César Rosa-Neto
Emídio Marques Matos-Neto
Paulo S. M. Alcântara
Flavio Tokeshi
Linda Ferreira Maximiano
Fang Chia Bin
Fernanda Bellotti Formiga
José P. Otoch
José P. Otoch
Marilia Seelaender
Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia
Frontiers in Immunology
neoplasms
cachexia
adipose tissue heterogeneity
inflammation
NLRP3 inflammasome
author_facet Joyce de Cassia Rosa de Jesus
Ariene Soares de Pinho Murari
Katrin Radloff
Ruan Carlos Macêdo de Moraes
Raquel Galvão Figuerêdo
Ana Flavia Marçal Pessoa
José César Rosa-Neto
Emídio Marques Matos-Neto
Paulo S. M. Alcântara
Flavio Tokeshi
Linda Ferreira Maximiano
Fang Chia Bin
Fernanda Bellotti Formiga
José P. Otoch
José P. Otoch
Marilia Seelaender
author_sort Joyce de Cassia Rosa de Jesus
title Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia
title_short Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia
title_full Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia
title_fullStr Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia
title_full_unstemmed Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer Cachexia
title_sort activation of the adipose tissue nlrp3 inflammasome pathway in cancer cachexia
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-09-01
description BackgroundCachexia is a paraneoplastic syndrome that accompanies and compromises cancer treatment, especially in advanced stages, affecting the metabolism and function of several organs. The adipose tissue is the first to respond to the presence of the tumor, contributing to the secretion of factors which drive the systemic inflammation, a hallmark of the syndrome. While inflammation is a defensive innate response, the control mechanisms have been reported to be disrupted in cachexia. On the other hand, little is known about the role of NLRP3 inflammasome in this scenario, a multiprotein complex involved in caspase-1 activation and the processing of the cytokines IL-1β and IL-18.Aimbased on the evidence from our previous study with a rodent model of cachexia, we examined the activation of the NLRP3 inflammasome pathway in two adipose tissue depots obtained from patients with colorectal cancer and compared with that another inflammatory pathway, NF-κB.ResultsFor CC we found opposite modulation in ScAT and PtAT for the gene expression of TLR4, Caspase-1 (cachectic group) and for NF-κB p50, NF-κB p65, IL-1β. CD36, expression was decreased in both depots while that of NLRP3 and IL-18 was higher in both tissues, as compared with controls and weight stable patients (WSC). Caspase-1 basal protein levels in the ScAT culture supernatant were higher in WSC and (weight stable patients) CC, when compared to controls. Basal ScAT explant culture medium IL-1β and IL-18 protein content in ScAT supernatant was decreased in the WSC and CC as compared to CTL explants.ConclusionsThe results demonstrate heterogeneous responses in the activation of genes of the NLRP3 inflammasome pathway in the adipose tissue of patients with cancer cachexia, rendering this pathway a potential target for therapy aiming at decreasing chronic inflammation in cancer.
topic neoplasms
cachexia
adipose tissue heterogeneity
inflammation
NLRP3 inflammasome
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.729182/full
work_keys_str_mv AT joycedecassiarosadejesus activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT arienesoaresdepinhomurari activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT katrinradloff activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT ruancarlosmacedodemoraes activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT raquelgalvaofigueredo activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT anaflaviamarcalpessoa activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT josecesarrosaneto activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT emidiomarquesmatosneto activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT paulosmalcantara activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT flaviotokeshi activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT lindaferreiramaximiano activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT fangchiabin activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT fernandabellottiformiga activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT josepotoch activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT josepotoch activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
AT mariliaseelaender activationoftheadiposetissuenlrp3inflammasomepathwayincancercachexia
_version_ 1717370589792960512
spelling doaj-27a84ec0b70242688c13eb621805645e2021-09-23T05:56:01ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-09-011210.3389/fimmu.2021.729182729182Activation of the Adipose Tissue NLRP3 Inflammasome Pathway in Cancer CachexiaJoyce de Cassia Rosa de Jesus0Ariene Soares de Pinho Murari1Katrin Radloff2Ruan Carlos Macêdo de Moraes3Raquel Galvão Figuerêdo4Ana Flavia Marçal Pessoa5José César Rosa-Neto6Emídio Marques Matos-Neto7Paulo S. M. Alcântara8Flavio Tokeshi9Linda Ferreira Maximiano10Fang Chia Bin11Fernanda Bellotti Formiga12José P. Otoch13José P. Otoch14Marilia Seelaender15Cancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilImmunometabolism Laboratory, Institute of Biomedical Sciences, Universidade de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilUniversity Hospital, Department of Surgical Clinic, Universidade de São Paulo, São Paulo, BrazilUniversity Hospital, Department of Surgical Clinic, Universidade de São Paulo, São Paulo, BrazilUniversity Hospital, Department of Surgical Clinic, Universidade de São Paulo, São Paulo, BrazilDepartment of Coloproctology, Santa Casa de São Paulo, São Paulo, BrazilDepartment of Coloproctology, Santa Casa de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilUniversity Hospital, Department of Surgical Clinic, Universidade de São Paulo, São Paulo, BrazilCancer Metabolism Research Group, Department of Surgery Laboratório de Investigação Médica (LIM26), Faculdade de Medicina, Universidade de São Paulo, São Paulo, BrazilBackgroundCachexia is a paraneoplastic syndrome that accompanies and compromises cancer treatment, especially in advanced stages, affecting the metabolism and function of several organs. The adipose tissue is the first to respond to the presence of the tumor, contributing to the secretion of factors which drive the systemic inflammation, a hallmark of the syndrome. While inflammation is a defensive innate response, the control mechanisms have been reported to be disrupted in cachexia. On the other hand, little is known about the role of NLRP3 inflammasome in this scenario, a multiprotein complex involved in caspase-1 activation and the processing of the cytokines IL-1β and IL-18.Aimbased on the evidence from our previous study with a rodent model of cachexia, we examined the activation of the NLRP3 inflammasome pathway in two adipose tissue depots obtained from patients with colorectal cancer and compared with that another inflammatory pathway, NF-κB.ResultsFor CC we found opposite modulation in ScAT and PtAT for the gene expression of TLR4, Caspase-1 (cachectic group) and for NF-κB p50, NF-κB p65, IL-1β. CD36, expression was decreased in both depots while that of NLRP3 and IL-18 was higher in both tissues, as compared with controls and weight stable patients (WSC). Caspase-1 basal protein levels in the ScAT culture supernatant were higher in WSC and (weight stable patients) CC, when compared to controls. Basal ScAT explant culture medium IL-1β and IL-18 protein content in ScAT supernatant was decreased in the WSC and CC as compared to CTL explants.ConclusionsThe results demonstrate heterogeneous responses in the activation of genes of the NLRP3 inflammasome pathway in the adipose tissue of patients with cancer cachexia, rendering this pathway a potential target for therapy aiming at decreasing chronic inflammation in cancer.https://www.frontiersin.org/articles/10.3389/fimmu.2021.729182/fullneoplasmscachexiaadipose tissue heterogeneityinflammationNLRP3 inflammasome